Royal Bank of Canada Boosts Xylem (NYSE:XYL) Price Target to $162.00

Xylem (NYSE:XYLFree Report) had its price objective hoisted by Royal Bank of Canada from $157.00 to $162.00 in a research note issued to investors on Friday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the industrial products company’s stock.

Other equities analysts have also recently issued reports about the company. Raymond James raised Xylem from an underperform rating to a market perform rating in a report on Thursday, January 4th. Robert W. Baird raised their target price on Xylem from $151.00 to $155.00 and gave the stock an outperform rating in a research report on Friday. Oppenheimer upped their price target on shares of Xylem from $142.00 to $147.00 and gave the company an outperform rating in a research report on Friday. Stifel Nicolaus raised their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a buy rating in a report on Wednesday, February 7th. Finally, Mizuho boosted their target price on shares of Xylem from $110.00 to $135.00 and gave the company a neutral rating in a research report on Friday. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus price target of $140.70.

Check Out Our Latest Analysis on Xylem

Xylem Trading Up 0.9 %

Xylem stock opened at $137.21 on Friday. Xylem has a one year low of $87.59 and a one year high of $138.46. The business’s fifty day moving average is $128.64 and its 200 day moving average is $115.54. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.67 and a quick ratio of 1.30. The stock has a market capitalization of $33.26 billion, a PE ratio of 48.83, a price-to-earnings-growth ratio of 2.69 and a beta of 1.08.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.06. The firm had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business’s quarterly revenue was up 40.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.72 EPS. On average, sell-side analysts predict that Xylem will post 4.24 EPS for the current year.

Xylem Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were given a $0.36 dividend. This is a positive change from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date of this dividend was Tuesday, February 20th. Xylem’s dividend payout ratio is presently 51.25%.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Institutional Trading of Xylem

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Commonwealth Equity Services LLC increased its holdings in shares of Xylem by 0.9% in the third quarter. Commonwealth Equity Services LLC now owns 69,566 shares of the industrial products company’s stock worth $6,333,000 after purchasing an additional 645 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Xylem by 3.1% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 18,603 shares of the industrial products company’s stock worth $1,693,000 after acquiring an additional 553 shares in the last quarter. Xponance Inc. boosted its position in shares of Xylem by 2.6% during the 3rd quarter. Xponance Inc. now owns 36,754 shares of the industrial products company’s stock valued at $3,346,000 after acquiring an additional 938 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Xylem by 21.2% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 23,782 shares of the industrial products company’s stock valued at $2,165,000 after purchasing an additional 4,157 shares in the last quarter. Finally, Bailard Inc. grew its holdings in shares of Xylem by 8.7% in the third quarter. Bailard Inc. now owns 22,371 shares of the industrial products company’s stock valued at $2,036,000 after purchasing an additional 1,788 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.